The Fate of Oligonucleotide Medications

Veliterbio28 Oct, 2024Business

Oligonucleotide drugs are rapidly gaining a central place in todayÕs pharmaceutical industry. These synthetic molecules of DNA or RNA are meant for selective action on definite genes associated with diseases. This makes oligonucleotide drugs development different from most other drugs, which target proteins or enzymes, because, in principle, one could design drugs that alter genetic activity. This indicates that there can be fresh approaches for managing many disorders, including inherited disorders, cancer, and diabetes.